The combination drug acetylsalicylic acid/dipyridamole (trade names Aggrenox and others) is a drug combination of:
The combination acts as an extended release formulation and is primarily used for platelet inhibition in patients suffering, or at risk from, acute coronary events and stroke. Its use has been shown to be better than the use of either dipyridamole or aspirin alone.